- ʻO ka hoʻāʻo hoʻokolohua ʻana ma 24 mau mea manawaleʻa ʻole i hōʻoia ʻole ʻia no kahi mana capsule hoʻokahi o ka lāʻau āpau i ʻae ʻia.
- Hiki ke hoʻohana ʻia ka capsule ma ke ʻano he booster e kūʻē i ka Delta ʻano nui loa lele.
- Ua hoʻāʻo ka pila i nā puaʻa a ua hana nā holoholona i nā meaola ma hope o ka lawelawe ʻia ʻana.
Ma Ierusalema Nā lāʻau lapaʻau i hoʻōla ʻia ua hoʻolaha ʻia ua ʻae ʻia mai ka Tel Aviv Sourasky Medical Center e hoʻomaka i kahi hoʻokolohua hoʻokolohua ma 24 mau mea manawaleʻa ʻole i hoʻoponopono ʻia no kahi mana capsule hoʻokahi o kahi lāʻau COVID-19.
Ua hoʻolaha ʻo Oramed iā Malaki ua hoʻāʻo ʻo ia i kāna pila ma nā puaʻa a ua hana nā holoholona i nā meaola ma hope o ka lawelawe ʻia ʻana.
Hiki i kahi pill version of coronavirus vaccine ke lilo i "game changer" i nā ʻāina me ka haʻahaʻa haʻahaʻa, ua ʻōlelo ka mea hoʻomohala.
ʻO ka ʻoihana loea i ka hana ʻana i nā mana waha o nā lāʻau i lawelawe pinepine ʻia ma o ka hoʻopili ʻana, ke hana nei nō hoʻi i kēia manawa i nā hoʻokolohua no kāna capsule insulin waha e mālama i ka maʻi diabetes Type-2. Ke mālama ʻia nei nā lāʻau āpau COVID-19 āpau i kēia manawa ma o hoʻokahi a ʻelua paha inikua.
Wahi a ka CEO ʻo Oramed Nadav Kidron, e hoʻomaka ana ka hoʻokolokolo no ka lāʻau lapaʻau vaccine COVID-19 i ka mahina e hiki mai ana, ke loaʻa i ka ʻae hope loa mai ke Kuhina olakino.
Ua hoʻohui ʻo Kidron e hiki ke hoʻohana ʻia ka pila ma ke ʻano he booster e kūʻē i ka Delta variag contactious.
"ʻO kā mākou lāʻau āpau waha ʻole, ka mea hilinaʻi ʻole i kahi kaula lako hohonu i kūlike ʻole me nā lāʻau coronavirus ʻē aʻe, ʻo ia paha ka ʻokoʻa āpau ma waena o kahi ʻāina i hiki ke puka aʻe mai ka maʻi ahulau a ʻaʻole paha," i ʻōlelo ʻo Kidron.
He aha e lawe ʻia mai kēia ʻatikala:
- Jerusalem-based Oramed Pharmaceuticals announced that is has received approval from the Tel Aviv Sourasky Medical Center to start a clinical trial on 24 unvaccinated volunteers for a single-dose capsule version of a COVID-19 vaccine.
- A pill version of coronavirus vaccine could be a “game changer” in countries with a low vaccination rate, the developer has said.
- Wahi a ka CEO ʻo Oramed Nadav Kidron, e hoʻomaka ana ka hoʻokolokolo no ka lāʻau lapaʻau vaccine COVID-19 i ka mahina e hiki mai ana, ke loaʻa i ka ʻae hope loa mai ke Kuhina olakino.
